Cargando…
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas
There are no studies comparing the prognosis for mature T-cell lymphoma (TCL) in people with HIV (PWH) to people without HIV (PWoH) and to AIDS-defining B-cell lymphomas (A-BCLs) in the modern antiretroviral therapy era. North American AIDS Cohort Collaboration on Research and Design and Comprehensi...
Autores principales: | Koh, Min Jung, Merrill, Mwanasha H., Koh, Min Ji, Stuver, Robert, Alonso, Carolyn D., Foss, Francine M., Mayor, Angel M., Gill, John, Epeldegui, Marta, Cachay, Edward, Thorne, Jennifer E., Silverberg, Michael J., Horberg, Michael A., Althoff, Keri N., Nijhawan, Ank E., McGinnis, Kathleen A., Lee, Jennifer S., Rabkin, Charles S., Napravnik, Sonia, Li, Jun, Castilho, Jessica L., Shen, Changyu, Jain, Salvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905704/ https://www.ncbi.nlm.nih.gov/pubmed/35026839 http://dx.doi.org/10.1182/bloodadvances.2021006208 |
Ejemplares similares
-
Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis
por: Shafagati, Nazila, et al.
Publicado: (2022) -
Retrospective characterization of nodal marginal zone lymphoma
por: Stuver, Robert, et al.
Publicado: (2023) -
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
por: Potnis, Kunal C., et al.
Publicado: (2022) -
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
por: Johnson, William T., et al.
Publicado: (2023) -
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations
por: Koh, Jiwon, et al.
Publicado: (2021)